Home Florida Cities with Medical Doctor Providers Fort Lauderdale

Medical Doctor GARY RICHMOND

GARY RICHMOND is a Florida Medical Doctor with their office listed as being located at: 812 SW 12 Avenue in FORT LAUDERDALE, Florida 33312 Any education information we have on file, publications, awards, certifications, hospital priviliges, directions can be found below. Thanks and we hope you find what you are looking for.

Get mobile directions from current location:

---

FL License Details
Full Name: GARY RICHMOND
License: ME48892
Profession Name: Medical Doctor
License Created on: 07/18/1986
City: FORT LAUDERDALE
Prescribing Indicator: Y

---

---

Listed Education

---

Bachelor's Information:
Degree Earned: MD

---

Internships, Residency Programs, Fellowships etc
Program Location:BETH ISRAEL MEDICAL CENTER
Program:IM - INTERNAL MEDICINE
Program Type:INTERNSHIP
Program Location:BETH ISRAEL MEDICAL CENTER
Program:IM - INTERNAL MEDICINE
Program Type:RESIDENCY
Program Location:BETH ISRAEL MEDICAL CENTER
Program:IM - PULMONARY DISEASE
Program Type:FELLOWSHIP
Program Location:UNIVERSITY OF CALIFORNIA IN SAN FRANCISCO SCHOOL OF MEDICI
Program:IM - PULMONARY DISEASE
Program Type:FELLOWSHIP

---

Certifications

IM - INTERNAL MEDICINE from AMERICAN BOARD OF INTERNAL MEDICINE
IM - PULMONARY DISEASE from AMERICAN BOARD OF INTERNAL MEDICINE

---

Hospital Privileges

Hospital and state it is in: BROWARD GENERAL MEDICAL CENTER in FL
Hospital and state it is in: HOLY CROSS HOSPITAL, INC. in FL

---

Faculty Appointments

Title and School: CLINICAL ASSOCIATE PROFESSOR at FLORIDA INTERNATIONAL UNIV. COLLEGE OF MEDICINE in MIAMI,FL

---

Article Publications

Article title, publication, and date: PRIMARY PULMONARY HYPERTENSION at HUMAN PATHOLOGY on 01/01/1992
Article title, publication, and date: SUPERIOR VENAL CAVAL SYNDROME at NY STATE J. MEDICINE on 01/01/1992
Article title, publication, and date: ONCE DAILY ABACAVIR LAMIVUDINE AND RITONAVIR BOOSTED ATAZANA at HIV CLINICAL TRIALS on 09/01/2008
Article title, publication, and date: LONG TERM SAFETY TESAMAMORELIN at AIDS on 04/01/2008
Article title, publication, and date: SAFETY PHARMACOLOGY HGS004 IGG4 MONOCLONAL ANTIBODY at JOURNAL INFECTIOUS DISEASES on 09/01/2008
Article title, publication, and date: ENFUVIRTIDE DOSE ADJUSTMENT CHRONIC KIDNEY FAILURE at JOURANL OF AIDS on 06/01/2008
Article title, publication, and date: EFFECTS OF GROWTH HORMONE RELEASING FACTOR at NEW ENGLAND JOURNAL OF MEDICINE on 08/06/2007
Article title, publication, and date: T-1249 RETAINS POTENT ANTIRETROVIRAL ACTIVITY IN PATIENTS WH at JOURNAL INFECTIOUS DISEASE on 04/01/2005
Article title, publication, and date: PHARMACODYNAMIC EFFECTS OF ZIDOVUDINE 600 MG ONCE A DAY VERS at PHARMACOTHERAPY on 01/10/2004
Article title, publication, and date: Long Acting im Cabotegravir + Rilpivirine in adults with HIV at The Lancet on 07/24/2017
Article title, publication, and date: Dolutegravir versus placebo in subjects harbouring HIV-1 wit at Antiviral Therapy on 10/16/2014
Article title, publication, and date: Dolutegravir vs. raltegravir in antiretroviral experienced, at Lancet on 07/03/2013
Article title, publication, and date: Safety and Efficacy of Dolutegravir in HIV-1 Treatment Exper at Journal of Infectious Diseases on 03/01/2013
Article title, publication, and date: Simplified maintenance therapy with abacavir lamivudine and at HIV Clinical Trials on 05/11/2010
Article title, publication, and date: Atrial Septal Rupture, Flail Tricuspid Valve and Complete He at Annals of Thoracic Surgery on 06/10/2007
Article title, publication, and date: Recombinant Human Growth Hormone to Treat HIV Associated Adi at Journal of AIDS on 07/01/2007
Article title, publication, and date: Pharmacokinetics, pharmacodynamics, and safety of once daily at AIDS on 02/14/2006
Article title, publication, and date: Ibalizumab for multi drug resistant HIV at New England Journal of Medicine on 08/16/2018
Article title, publication, and date: Experiences with long acting injectable ART; qualitative stu at PLOS ONE on 01/05/2018
Article title, publication, and date: Long acting cabotegravir and rilpivirine dosed every 2 month at Lancet on 12/19/2020
Article title, publication, and date: Cabotegravir and Rilpivirine for virologically suppressed HI at New England Journal of Medicine on 03/19/2020
Article title, publication, and date: Long acting cabotegravir + Rilpivirine Pooled ATLAS FLAIR Tr at Journal of AIDS on 08/21/2020